GC-4702

N/A

Report date: 2022/08/30 20:00:42
NME

Base Information

Drug NameGC-4702
Drug Alias NameGC-4702
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuperoxide dismutase 3 modulators
TargetsSuperoxide dismutase 3
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGalera Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGalera Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A